Pancreatic Cell News Volume 14.27 | July 18 2023

    0
    17








    2023-07-18 | PACN 14.27


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 14.27 – 18 July, 2023
    TOP STORY

    Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting

    Patient-derived xenografts were generated from 25 patients with germline BRCA PDAC at different clinical time points. Response to platinum/PARP inhibition in vivo and ex vivo culture correlated with clinical response.
    [Cancer Discovery]

    Abstract
    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    PUBLICATIONSRanked by the impact factor of the journal

    Restoration of PITPNA in Type 2 Diabetic Human Islets Reverses Pancreatic Beta-Cell Dysfunction

    Phosphatidylinositol transfer protein alpha (PITPNA) in beta-cells of type 2 diabetes human subjects was markedly reduced suggesting its depletion accompanied beta-cell dysfunction.
    [Nature Communications]

    Full Article

    Protection of Pancreatic Islets from Oxidative Cell Death by a Peripherally-Active Morphinan with Increased Drug Safety

    Receptor and channel binding assays were conducted to evaluate the drug safety of a dextromethorphan derivative. Pancreatic islets were used to investigate the effect of the compound on insulin secretion and islet cell survival.
    [Molecular Metabolism]

    Full Article

    EndoC-βH5 Cells Are Storable and Ready-to-Use Human Pancreatic Beta Cells with Physiological Insulin Secretion

    EndoC-βH5 cells were generated by integrative gene transfer of immortalizing transgenes hTERT and SV40 large T along with Herpes Simplex Virus-1 thymidine kinase into human fetal pancreas.
    [Molecular Metabolism]

    Full Article

    IRAK3-Mediated Suppression of Pro-Inflammatory MyD88/IRAK Signaling Affects Disease Severity in Acute Pancreatitis

    Scientists investigated the role of MYD88/IRAK using Irak3−/− mice in two experimental animal models of mild and severe acute pancreatitis. IRAK3 was expressed in macrophages as well as pancreatic acinar cells, where it restrained NFκB activation.
    [Scientific Reports]

    Full Article

    BICC1 Drives Pancreatic Cancer Progression by Inducing VEGF-Independent Angiogenesis

    Mechanistically, as an RNA binding protein, BICC1 bound to the 3’UTR of Lipocalin-2 mRNA and post-transcriptionally up-regulated LCN2 expression in pancreatic adenocarcinoma cells.
    [Signal Transduction And Targeted Therapy]

    Full Article

    Genome-Wide CRISPR Screens Define Determinants of Epithelial-Mesenchymal Transition Mediated Immune Evasion by Pancreatic Cancer Cells

    Scientists showed that mesenchymal-like KPC3 pancreatic cancer cells were more resistant to cytotoxic T lymphocyte–mediated killing than the parental epithelial–like cells.
    [Science Advances]

    Full Article

    Targeted Nanodelivery of siRNA against KRAS G12D Inhibits Pancreatic Cancer

    Investigators reported that cRGD peptide-modified bioresponsive chimaeric polymersomes mediated highly efficient siKRAS delivery to PANC-1 tumor, potently silencing KRAS G12D mRNA in tumor cells and effectively suppressing pancreatic cancer tumor growth in mice.
    [Acta Biomaterialia]

    AbstractGraphical Abstract

    High-Throughput Functional Screen Identifies YWHAZ as a Key Regulator of Pancreatic Cancer Metastasis

    Researchers identified YWHAZ as a key regulator of pancreatic cancer metastasis, and demonstrated that functional activation of Ywhaz by the gene search vector led to enhanced metastatic capability in mouse pancreatic cancer cells.
    [Cell Death & Disease]

    Full ArticleGraphical Abstract
    Watch a webinar on using patient-derived iPS cells to model diabetes.
    REVIEWS

    Molecular Profile of Metastasis, Cell Plasticity and EMT in Pancreatic Cancer: A Pre-Clinical Connection to Aggressiveness and Drug Resistance

    The authors review the molecular mechanisms, and other factors related to the metastasis of pancreatic cancer, and discuss the consequences and negative effects associated with metastasis itself.
    [Cancer And Metastasis Reviews]

    AbstractGraphical Abstract

    Intrapancreatic Fat, Pancreatitis, and Pancreatic Cancer

    Scientists review studies addressing the accumulation and activity of intrapancreatic adipocytes in the pancreas (IPAs), revealing that an unexpectedly diverse group of factors cause replacement of acinar tissue with IPAs, particularly in the mouse models that are essential tools for research into pancreatic cancer.
    [Cellular And Molecular Life Sciences]

    Full Article
    INDUSTRY AND POLICY NEWS

    ImPact Biotech Receives FDA Orphan Drug Designation for Padeliporfin VTP in Pancreatic Cancer

    ImPact Biotech announced the FDA granted Orphan Drug Designation to Padeliporfin Vascular Targeted Photodynamic therapy (VTP) for the treatment of patients with locally advanced pancreatic cancer.
    [ImPact Biotech (GlobalNewswire)]

    Press Release
    FEATURED EVENT

    AFLAS Congress 2023

    September 13 – 15, 2023
    Seogwipo, South Korea

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Researcher – Pancreatic Cancer & Iron Metabolism

    Aarhus University – Aarhus, Denmark

    Postdoctoral Fellow – Pancreatic & Gastrointestinal Cancer

    Rutgers Cancer Institute of New Jersey – New Brunswick, New Jersey, United States

    PhD Position – Epigenetics & β Cells

    University of Southern Denmark – Odense, Denmark

    Research Fellow – Bile Acids in NAFLD & Insulin Resistance

    The National University of Singapore – Singapore, Singapore

    Postdoctoral Fellow – Diabetes Research

    City of Hope – Duarte, California, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter